Literature DB >> 16061284

Expression of natural cytotoxicity receptors NKp30, NKp44, and NKp46 mRNAs and proteins by human hematopoietic and non-hematopoietic cells.

Bejai I S Srivastava1, Maya D Srivastava.   

Abstract

T-cells and NK cells arise from common pluripotent stem cells, with shared early developmental pathway and surface markers. Distinguishing between them is becoming difficult, but critical for study. A large family of NK cells, including classical NK, NK-T, and NK-CTL exists. Natural cytotoxicity receptors (NKp46, NKp44, NKp30) have been proposed as specific for classical NK cells, but were expressed at protein and mRNA level by CD8+NK/T cell line SRIK-NKL, suggesting more widespread expression. We investigated and found expression of these markers at the protein and mRNA level in multiple human cell lines.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16061284     DOI: 10.1016/j.leukres.2005.06.020

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  10 in total

1.  Differential RNA expression of KIR alleles.

Authors:  Colum McErlean; Asensio A Gonzalez; Rodat Cunningham; Ashley Meenagh; Tanya Shovlin; Derek Middleton
Journal:  Immunogenetics       Date:  2010-05-08       Impact factor: 2.846

Review 2.  Vimentin in cancer and its potential as a molecular target for cancer therapy.

Authors:  Arun Satelli; Shulin Li
Journal:  Cell Mol Life Sci       Date:  2011-06-03       Impact factor: 9.261

3.  The stalk domain and the glycosylation status of the activating natural killer cell receptor NKp30 are important for ligand binding.

Authors:  Jessica Hartmann; Thuy-Van Tran; Janina Kaudeer; Karin Oberle; Julia Herrmann; Isabell Quagliano; Tobias Abel; André Cohnen; Volker Gatterdam; Andrea Jacobs; Bernd Wollscheid; Robert Tampé; Carsten Watzl; Andreas Diefenbach; Joachim Koch
Journal:  J Biol Chem       Date:  2012-07-17       Impact factor: 5.157

4.  Copy number variations of HLA-I and activation of NKp30 pathway determine the sensitivity of gastric cancer cells to the cytotoxicity of natural killer cells.

Authors:  R Xing; L Li; L Chen; Z Gao; H Wang; W Li; J Cui; G Tian; Q Liang; J Yu; J J Sung; G Luo; H Gao; X Xu; H Yang; J Wang; X Zhang; J M Wang; J Huang; Y Yu; J Wang; Y Lu
Journal:  Oncogene       Date:  2015-09-14       Impact factor: 9.867

5.  Identification and characterization of a transmembrane isoform of CD160 (CD160-TM), a unique activating receptor selectively expressed upon human NK cell activation.

Authors:  Jérôme Giustiniani; Armand Bensussan; Anne Marie-Cardine
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

6.  Beyond genome-wide scan: Association of a cis-regulatory NCR3 variant with mild malaria in a population living in the Republic of Congo.

Authors:  Sabrina Baaklini; Sarwat Afridi; Thy Ngoc Nguyen; Felix Koukouikila-Koussounda; Mathieu Ndounga; Jean Imbert; Magali Torres; Lydie Pradel; Francine Ntoumi; Pascal Rihet
Journal:  PLoS One       Date:  2017-11-09       Impact factor: 3.240

7.  Effect of low dose IL-2 loaded chitosan nanoparticles on natural killer and regulatory T cell expression in experimentally induced autoimmune type 1 diabetes mellitus.

Authors:  Salma Aboelnazar; Hossam Ghoneim; Thanaa Shalaby; Eman Bahgat; Mai Moaaz
Journal:  Cent Eur J Immunol       Date:  2021-01-30       Impact factor: 2.085

8.  Low-dose interleukin-2-loaded nanoparticle effect on NK and T-reg cell expression in experimentally induced type 1 diabetes mellitus.

Authors:  Salma Aboelnazar; Hossam Ghoneim; Mai Moaaz; Eman Taha Bahgat; Thanaa Shalaby
Journal:  Prz Gastroenterol       Date:  2021-03-26

9.  Systemic NK cell ablation attenuates intra-abdominal adipose tissue macrophage infiltration in murine obesity.

Authors:  Robert W O'Rourke; Kevin A Meyer; Christopher K Neeley; Garen D Gaston; Palak Sekhri; Marek Szumowski; Brian Zamarron; Carey N Lumeng; Daniel L Marks
Journal:  Obesity (Silver Spring)       Date:  2014-06-24       Impact factor: 5.002

10.  Heterogeneity of circulating CD8 T-cells specific to islet, neo-antigen and virus in patients with type 1 diabetes mellitus.

Authors:  Sandra Laban; Jessica S Suwandi; Vincent van Unen; Jos Pool; Joris Wesselius; Thomas Höllt; Nicola Pezzotti; Anna Vilanova; Boudewijn P F Lelieveldt; Bart O Roep
Journal:  PLoS One       Date:  2018-08-08       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.